Kezar Life Sciences diskutieren
Kezar Life Sciences
WKN: A2JPE7 / Symbol: KZR / Name: Kezar Life Sciences / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,69 €
-3,52 %
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its price target raised by analysts at HC Wainwright from $18.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for KZR provided by MarketBeat
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for KZR provided by MarketBeat
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for KZR provided by MarketBeat
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for KZR provided by MarketBeat
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for KZR provided by MarketBeat
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its price target lowered by analysts at HC Wainwright from $20.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for KZR provided by MarketBeat
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Ratings data for KZR provided by MarketBeat
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for KZR provided by MarketBeat
Kezar Life Sciences (NASDAQ:KZR) was upgraded by analysts at Wall Street Zen to a "sell" rating.
Ratings data for KZR provided by MarketBeat
Neueste Beiträge
Royal_Bank_of_Canada in Major Drilling Group Intl diskutieren